INS and type 2 diabetes mellitus: Five (one prospective and four retrospective) studies reported that the presence of GADA in type 2 diabetes increased the rate of diabetes progression denoted by insulin requirement44, 57, 58, 67 and glycaemic deterioration.50 These studies were conducted in European, Japanese and Korean populations.